Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Net Cash Flow (2020 - 2025)

Beauty Health (SKIN) has disclosed Net Cash Flow for 6 consecutive years, with $7.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Net Cash Flow fell 3.23% to $7.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$141.1 million, a 30.35% increase, with the full-year FY2024 number at -$149.0 million, down 215.65% from a year prior.
  • Net Cash Flow was $7.8 million for Q3 2025 at Beauty Health, up from -$165.3 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $618.0 million in Q3 2021 to a low of -$165.3 million in Q2 2025.
  • A 5-year average of $11.1 million and a median of $1.6 million in 2025 define the central range for Net Cash Flow.
  • Peak YoY movement for Net Cash Flow: surged 49658.3% in 2021, then plummeted 1017.83% in 2022.
  • Beauty Health's Net Cash Flow stood at $183.0 million in 2021, then crashed by 160.5% to -$110.7 million in 2022, then surged by 65.04% to -$38.7 million in 2023, then soared by 138.35% to $14.8 million in 2024, then crashed by 47.71% to $7.8 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Net Cash Flow are $7.8 million (Q3 2025), -$165.3 million (Q2 2025), and $1.6 million (Q1 2025).